Last week, I was looking at Google GOOGL 0.00%↑ .
This week? PepsiCo PEP 0.00%↑ .
From artificial intelligence to potato chips.
Welcome to my trading desk. 😂🥤
I don’t need every stock on my board to be exciting. I need a reason to own it, a reason to trade it, or preferably, both.
And that’s what caught my attention about PepsiCo (PEP).
I’m looking at two potential opportunities:
The investment: An established business trading below Morningstar’s fair-value estimate, with a substantial dividend while investors wait for a possible recovery.
The trade: An early technical recovery that could turn into a bread-and-butter swing trade toward the 200-day simple moving average (SMA).
→ Same stock. Two different plans.
Let’s see whether PEP earns its place.
Here’s the setup →
NIM Top Pick of the Week 👑
Ticker: PEP
Company: PepsiCo, Inc.
Sector: Consumer Staples XLP 0.00%↑
Industry: Soft Drinks
Valuation: Morningstar currently rates PEP five stars with a $169 fair-value estimate and a wide economic moat.
Dividend: Yes. PEP pays a quarterly dividend with a 4.67% yield.
Potential swing-trade target: 200-day SMA, around $143.96.
First, let’s start where every trade should start—with the Big Picture.
👑 WANT MORE TRADE IDEAS LIKE THIS?
For October, you can get 22% off an annual Nurse in the Market subscription.
Paid subscribers get my Sunday Market Playbook, Wednesday Top Pick of the Week, and the research and trade ideas I’m watching along the way.
22% off. October only. Come join us. 👑
The Big Picture: Market → Sector → Industry → Stock → Fundamental Analysis
You already know how I work.
Market first.
Then sector.
Then industry and stock.
Fundamental analysis.
I want as much working in my favor as possible before I take the trade and this week, the pieces are lining up.
I. The Market: The S&P 500 (SPY)
The market has been making new highs, but leadership beneath the surface is changing.
Technology XLK 0.00%↑ hasn’t been the only place attracting buyers. Defensive areas have started participating too.
That matters because I don’t want to evaluate PEP without understanding where money is moving.
The question isn’t whether PEP is more exciting than the latest AI stock.
→ It’s whether the market environment gives a defensive, dividend-paying business room to recover.
For that, I’m watching its sector.
II. The Sector: The XLP Has Broken Out
Consumer Staples XLP 0.00%↑ was one of the standouts in Sunday’s Market Playbook.
The XLP gained 3.60% over five trading days, broke out above its 20-day SMA, and reclaimed its 200-day SMA.
That’s a notable change in technical behavior. Now I want to see those reclaimed levels hold.
There’s one catch: PEP hasn’t confirmed the same breakout yet.
→ The sector is showing strength.
PEP is still trying to catch up and that gap between sector strength and stock confirmation is exactly why PEP is interesting to watch.
III. The Industry: What About KO & KDP?
I also looked at Coca-Cola KO 0.00%↑ and Keurig Dr Pepper KDP 0.00%↑ to put PEP’s chart in context, but there’s an important difference between these businesses.
PEP’s exposure goes well beyond beverages. Its snack brands are a major part of the story, so a comparison with KO or KDP alone doesn’t capture everything driving PEP’s results.
For now, I’m treating the peer charts as context rather than claiming PEP is the strongest stock in the group.
→ The XLP has confirmed its breakout. PEP still needs to confirm its own.
That’s the distinction I’m trading.
IV: The Business: Great Brands, Real Challenges
PEP owns brands people recognize without reading the label twice.
Pepsi.
Gatorade.
Mountain Dew.
Lay’s.
Doritos.
Cheetos.
That’s an appealing collection of everyday products, but familiar brands don’t make a stock immune to weak demand or margin pressure.
According to Morningstar’s October 9 analysis, PEP reported approximately 3% organic revenue growth in the third quarter, while North American food and beverage sales were roughly flat.
Core operating margin declined 35 basis points to 16.9%.
So the question isn’t whether PEP has recognizable products.
It does.
→ The question is whether the business can improve its growth and profitability enough to change how investors value the stock.
That’s the recovery case.
V. The Fundamental Valuation
Here’s where the longer-term opportunity gets interesting.
My October 13 Morningstar research showed:
Fair-value estimate: $169
Stock price: $127.30
Morningstar rating: 5 stars
Forward dividend yield: 4.67%
At that price, PEP was trading approximately 25% below Morningstar’s fair-value estimate.
That’s a meaningful discount, assuming the estimate holds up, and the dividend adds another reason to look.
A forward yield of 4.67% could appeal to investors willing to collect income while waiting for the business to recover, but I still want to monitor earnings, cash flow, debt, and dividend sustainability. A high yield doesn’t erase business risk.
For a long-term position, I’m interested in the combination of valuation, income, and a potential operating recovery.
For a swing trade? I’m looking at something else entirely.
PEP chart annotation →
VI. The PEP Chart
Here’s the technical picture:
I like that price has moved back above the 5-day and 10-day EMAs and I like that RSI is recovering and I like that the MACD histogram is beginning to improve.
Price is also starting to break above its 20-day SMA exhibiting a breakout it underway here.
Confirmation of a breakout would be price closing above its 20-day SMA.
Until then, I’m watching a developing setup—not an entry signal that’s already fired.
In other words:
→ this is an amazing buy & hold opportunity to pick up shares of PEP, an undervalued / dividend king & trophy stock to hold for the long-term, if not forever.
→ we can also position trade PEP back to true value and beyond and make massive gains.
→ we can take a simple swing trade to the 200-day SMA.
→ if you’re an experienced, astute trader, you can write option contracts on PEP and do what you do and make exponential gains.
👑 LIKE HOW WE BREAK DOWN A TRADE?
Market. Sector. Stock. Setup. Research.
That’s what we do inside Nurse in the Market every week.
For October, an annual subscription is 22% off, giving you access to the Sunday Market Playbook, Wednesday Top Pick of the Week, and the trade ideas and research I’m watching in between.
Come trade the Big Picture with us. 👑
My Plan: Two Ways to Play PEP
The Long-Term Dividend/Value Position
For a longer-term investment, the appeal is straightforward.
PEP is an established business trading below Morningstar’s estimated fair value of $169, with a dividend that may provide income while management works through its operating challenges.
The investment thesis depends on improving business performance and a sustainable dividend and it also requires patience.
A stock can remain undervalued for a long time.
The Simple Swing Trade
This is the technical opportunity I’m watching.
Potential trigger: A close above the 20-day SMA, approximately $128.21 on the October 13 chart.
Potential target: The 200-day SMA, approximately $143.96.
What would concern me: A failed breakout, renewed weakness below the short-term moving averages, or deteriorating sector conditions.
The distance from the October 13 price of $127.30 to the October 13 200-day SMA was approximately 13.1%.
That’s a useful reference point, but it isn’t the expected return on a trade entered later. The actual entry price and moving averages may be different when a signal appears.
I’d also need to identify a sensible invalidation level and evaluate the risk/reward before entering.
→ The $169 Morningstar faie value estimate belongs to the long-term valuation case. The 200-day SMA belongs to the swing-trade plan.
I don’t want to mix those targets up.
What Could Go Wrong?
Three things are at the top of my list.
The business recovery stalls. Weak demand and margin pressure could keep weighing on earnings.
The dividend becomes harder to support. Income is attractive only if the business can continue funding it.
The breakout fails. PEP could briefly reclaim its 20-day SMA, then reverse before getting anywhere near the 200-day SMA.
That’s why I’m interested in the opportunity without assuming the outcome.
The Bottom Line
PepsiCo PEP 0.00%↑ isn’t the flashiest stock on my board.
Good.
I’m watching a business with a potential valuation opportunity, an attractive dividend, and a technical setup that may be turning.
For the investor, it’s about value, income, and a possible business recovery.
For the trader, it’s about one question:
Can PEP close above its 20-day SMA and start working toward the 200-day?
That’s what I’m watching next. From Google to Doritos.
Different business. Different opportunity. Same trading discipline. 😂🥤
Following a systematic approach, reading market structure, and staying disciplined compounds over time.
Let me know what you’re watching and thank you so much for reading! 🙌
-Nurse Jess 🤝
Know the Big Picture. Focus on the Edge. 👑
Recent Articles
Top Pick of the Week: Google Again? Yep. And That’s Exactly the Point.
Alphabet Inc. was our Top Pick of the Week on June 17th and here we are in October and GOOGL is back.
Top Pick of the Week: Utilities Got Smashed. Now I Have My Trigger.
Sometimes the most interesting chart isn’t sitting at the top of the leaderboard.
Scan the QR code below to subscribe to Nurse in the Market →
📌 Bookmark this post. Track these setups through the week and see how they play out. This is how you develop an edge—by studying real-time trade ideas and learning what works.
Financial Disclaimer: This is not financial advice. All trades carry risk. Biotech stocks are highly volatile and speculative. Always do your own due diligence and consult with a financial advisor before making investment decisions.
From Google to Doritos. What a week at the trading desk. 😂🥤
PEP caught my attention for TWO reasons: the potential dividend/value opportunity and a possible swing trade toward the 200-day SMA.
But I'm waiting for the chart to confirm.
What about you? Would you consider PEP for the dividend, the trade, both—or neither? 👀👑
The polar bear for Pepsi has always been elite marketing!!! lol great article Jess as always!!!!